“Refractory thrombocytopenia after 177Lu-PSMA therapy: bone marrow infiltration (myelophthisis) versus treatment toxicity”, SRINMED, c. 3, sy 1, ss. 39–46, Nis. 2026, doi: 10.37609/srinmed.63.